The effect of topical ketorolac tromethamine on macular thickening after phacoemulsification in diabetic patients

Abstract Background To determine the effect of ketorolac tromethamine 0.5% in preventing post-phacoemulsification macular thickening. This randomized clinical trial. patients randomized 1:1 to receive either topical ketorolac three times a day or a placebo. Methods A total of 101 eyes of 101 diabeti...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hossein Mohammad-Rabei, Hamideh Sabbaghi, Mehdi Emamverdi, Saeed Karimi, Alireza Ramezani, Homayoun Nikkhah, Bahareh Kheiri, Mehdi Yaseri, Kourosh Sheibani, Razieh Bahreini
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2023-07-01
Edice:	BMC Ophthalmology
Témata:	Phacoemulsification Ketorolac Tromethamine Central Retinal Thickness Diabetes
On-line přístup:	https://doi.org/10.1186/s12886-023-03077-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!